Evidence map›Paper›PMID 28786837›Full record

ReviewCurrent opinion in pediatrics2017

A primer to clinical genome sequencing.

James R Priest

Abstract readReview
In one paragraph

Review in Current opinion in pediatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Prenatal exome and genome sequencing for fetal structural abnormalities.American journal of obstetrics and gynecology · 2023
    Review
  3. Article
  4. Article
  5. The Architecture of a Precision Oncology Platform.Advances in experimental medicine and biology · 2022
    Review
  6. Review
  7. Parental Attitudes Toward Clinical Genomic Sequencing in Children With Critical Cardiac Disease.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2021
    Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

James R PriestPediatric Cardiology, Stanford University School of Medicine, Lucile Packard Children's Hospital, Stanford, California, USA.

Funding

Genetic Mechanisms of Congenital Heart DiseaseR00HL130523 · NHLBI · STANFORD UNIVERSITY · PI PRIEST, JAMES R. · 2017 to 2019
$747k
Genetic Mechanisms of Congenital Heart DiseaseK99HL130523 · NHLBI · STANFORD UNIVERSITY · PI PRIEST, JAMES R. · 2016 to 2017
$306k
NHLBI NIH HHS K99 HL130523NHLBI NIH HHS R00 HL130523
6 · The paper itself

Abstract

purpose of reviewGenome sequencing is now available as a clinical diagnostic test. There is a significant knowledge and translation gap for nongenetic specialists of the processes necessary to generate and interpret clinical genome sequencing. The purpose of this review is to provide a primer on contemporary clinical genome sequencing for nongenetic specialists describing the human genome project, current techniques and applications in genome sequencing, limitations of current technology, and techniques on the horizon. RECENT

findingsAs currently implemented, genome sequencing compares short pieces of an individual's genome with a reference sequence developed by the human genome project. Genome sequencing may be used for obtaining timely diagnostic information, cancer pharmacogenomics, or in clinical cases when previous genetic testing has not revealed a clear diagnosis. At present, the implementation of clinical genome sequencing is limited by the availability of clinicians qualified for interpretation, and current techniques in used clinical testing do not detect all types of genetic variation present in a single genome. SUMMARY: Clinicians considering a genetic diagnosis have wide array of testing choices which now includes genome sequencing. Although not a comprehensive test in its current form, genome sequencing offers more information than gene-panel or exome sequencing and has the potential to replace targeted single-gene or gene-panel testing in many clinical scenarios.

Indexed as

Whole Genome SequencingGenetic TestingHuman Genome ProjectHumans

Identifiers

PMID28786837
PMCPMC5590671

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.